Bio
Dr. Kalbasi is a physician-scientist at the Stanford Cancer Institute, specializing in the treatment of patients with sarcoma, melanoma and other solid tumors. He actively leads early phase clinical trials related to immunotherapy and radiation therapy.
The Kalbasi laboratory studies cancer immunology, with a focus on understanding—and re-engineering—the molecular conversations that immune cells have with one another and with cancer cells, especially through cytokines. By mapping how these signals are sent, received, and interpreted within immune cells and cancer cells, the lab aims to design next-generation immunotherapies that deliver the right messages at the right time—making cancer-fighting cells more potent, more persistent, and more precise.
